Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 23 2023 - 11:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2023
Commission File Number: 001-38524
Titan Medical Inc.
(Exact Name of Registrant as Specified in Charter)
76 Berkeley Street
Toronto, Ontario M5A 2W7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20- F X ☒ Form 40- F
☐
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
TITAN MEDICAL INC. |
|
|
|
(Registrant) |
|
|
|
|
|
|
Date: |
March 23, 2023 |
By: |
/s/ Stephen Lemieux |
|
|
|
Name: |
Stephen Lemieux |
|
|
|
Title: |
Chief Financial Officer |
|
EXHIBIT INDEX
Titan Medical (PK) (USOTC:TMDIF)
Historical Stock Chart
From Jan 2025 to Feb 2025
Titan Medical (PK) (USOTC:TMDIF)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Titan Medical Inc (PK) (OTCMarkets): 0 recent articles
More Titan Medical Inc News Articles